General Practice Medical Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Innovation Institute for Integration of Medicine and Engineering, West China Hospital, Sichuan University, No.37 Guoxuexiang Road, Chengdu City, Sichuan, 610041, People's Republic of China.
BMC Med Res Methodol. 2024 Oct 28;24(1):255. doi: 10.1186/s12874-024-02381-5.
Accurate reporting of outcomes is crucial for interpreting the results of randomized controlled trials (RCTs). However, selectively reporting outcomes in publications to achieve researchers' anticipated results still occurs frequently. This study aims to investigate the prevalence of selective reporting of outcomes in RCTs on treating acute ischemic stroke (AIS), identify factors contributing to this issue, and assess its potential impact on the degree and direction of intervention effect.
A search was conducted in MEDLINE, Embase, and the Cochrane Library to collect interventional RCTs on AIS published from 2020 to 2022. Full texts of RCTs were reviewed, and only those reporting International Clinical Trials Registry Platform primary registry numbers were included. Registration information of the RCTs was extracted from the registry platforms and compared with the publications' details to assess the selective reporting of outcomes. Bayesian multilevel logistic regression was used to analyze the reasons behind selective reporting.
Among the total of 159 AIS RCTs identified, 82 (51.6%) were ultimately included, as they reported registration numbers, which encompassed 819 outcomes. Among them, 72 RCTs (87.8%) and 497 outcomes (60.7%) exhibited selective reporting. Omission-type selective reporting (downgrading, omitting, or ambiguously reporting) accounted for 36.4%, while addition-type selective reporting (upgrading, adding, or altering the measurement scope of outcomes) comprised 63.6%. Omission-type selective reporting correlated with negative results (OR: 7.39; 95% CI: 4.08-13.44), whereas addition-type selective reporting correlated with positive results (OR: 2.07; 95% CI: 1.34-3.26) and publication in journals that are not in the top quartile of the Journal Citation Reports (OR: 2.48; 95% CI: 1.15-5.38).
Registered interventional AIS RCTs still face significant issues regarding selective reporting of outcomes. Therefore, it is necessary to further evaluate the influence of selective reporting bias on the positive results obtained from individual AIS RCTs and the systematic reviews based on these RCTs.
准确报告结局对于解释随机对照试验(RCT)的结果至关重要。然而,研究人员仍经常选择性地在出版物中报告结局以获得预期结果。本研究旨在调查急性缺血性脑卒中(AIS)治疗 RCT 中选择性报告结局的发生率,确定导致这一问题的因素,并评估其对干预效果程度和方向的潜在影响。
检索 MEDLINE、Embase 和 Cochrane Library 以收集 2020 年至 2022 年发表的 AIS 干预性 RCT。对 RCT 的全文进行了审查,仅纳入了报告国际临床试验注册平台一级注册号码的 RCT。从注册平台提取 RCT 的注册信息,并与出版物的详细信息进行比较,以评估结局的选择性报告。采用贝叶斯多水平逻辑回归分析选择性报告的原因。
共确定了 159 项 AIS RCT,最终纳入了 82 项(51.6%),因为它们报告了注册号码,涵盖了 819 个结局。其中,72 项 RCT(87.8%)和 497 个结局(60.7%)存在选择性报告。遗漏型选择性报告(降级、遗漏或模糊报告)占 36.4%,而添加型选择性报告(升级、添加或改变结局的测量范围)占 63.6%。遗漏型选择性报告与阴性结果相关(OR:7.39;95%CI:4.08-13.44),而添加型选择性报告与阳性结果相关(OR:2.07;95%CI:1.34-3.26),且发表在期刊引文报告(JCR)未进入前四分位的期刊(OR:2.48;95%CI:1.15-5.38)。
已注册的 AIS 干预性 RCT 仍存在结局选择性报告的重大问题。因此,有必要进一步评估选择性报告偏倚对个别 AIS RCT 阳性结果的影响,以及基于这些 RCT 的系统评价。